Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 3, 709 (1 July 1997) | doi:10.1038/nm0797-709a;
Breast cancer susceptibility tests still valid, companies argue
Abstract
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
